NPI: 1043321532 · EASTON, MD 21601 · Durable Medical Equipment & Medical Supplies · NPI assigned 08/31/2006
Authorized official SMITH, DAVID controls 20+ related entities in our dataset. Read more
| Authorized Official | SMITH, DAVID (PRESIDENT) |
| NPI Enumeration Date | 08/31/2006 |
Other providers sharing the same authorized official: SMITH, DAVID
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,409 | $42K |
| 2019 | 1,200 | $26K |
| 2020 | 1,698 | $222K |
| 2021 | 1,437 | $142K |
| 2022 | 1,742 | $156K |
| 2023 | 1,183 | $169K |
| 2024 | 490 | $60K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 826 | 467 | $303K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,753 | 3,216 | $245K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,002 | 776 | $92K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,490 | 2,151 | $76K |
| 96375 | Therapeutic injection; each additional sequential IV push | 233 | 125 | $33K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 497 | 373 | $24K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 173 | 119 | $21K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 18 | 12 | $11K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 56 | 55 | $9K |
| 99215 | Prolong outpt/office vis | 91 | 76 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 20 | 16 | $918.98 |